Gabelli Funds’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9M Buy
+954,910
New +$11.4M 0.08% 290
2025
Q4
Sell
-27,527
Closed -$294K 1277
2025
Q3
$294K Sell
27,527
-8,811
-24% -$86.5K ﹤0.01% 1111
2025
Q2
$352K Buy
+36,338
New +$375K ﹤0.01% 1071
2022
Q2
Sell
-15,750
Closed -$550K 1411
2022
Q1
$550K Sell
15,750
-10,000
-39% -$342K ﹤0.01% 1029
2021
Q4
$784K Sell
25,750
-925
-3% -$30.1K ﹤0.01% 972
2021
Q3
$875K Sell
26,675
-9,601
-26% -$307K 0.01% 939
2021
Q2
$1.1M Buy
+36,276
New +$1.19M 0.01% 891

Other funds holding OGN

Gabelli Funds's OGN Position: Q2 2026 in Review

Gabelli Funds opened a new position in Organon & Co (OGN) in Q2 2026: 954,910 shares worth $12.9M. The stake represents 0.08% of the portfolio and ranks #290 among its holdings. This is a return to the name: Gabelli Funds previously reported a position in OGN as recently as Q3 2025.

Gabelli Funds first reported a position in OGN in Q2 2021 and has held it in 7 quarters since. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Gabelli Funds held 954,910 shares of Organon & Co worth $12.9M as of Q2 2026.
  • Organon & Co was a new Gabelli Funds position in Q2 2026.
  • Organon & Co made up 0.08% of Gabelli Funds's portfolio in Q2 2026, its #290 holding.
  • Gabelli Funds first reported a position in Organon & Co in Q2 2021 and has held it in 7 quarters since.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.